Disease response and patient-reported outcomes among initiators of ixekizumab.

Mona ShahriariRyan W HarrisonRussel BurgeChen-Yen LinWilliam N MalatestinicOrin M GoldblumRobert R McLeanMargaux M CrabtreeJacqueline O'BrienElsie L GraceMwangi J Murage

Published in: The Journal of dermatological treatment (2020)

We provide real-world evidence on the benefits of ixekizumab for treating psoriasis, regardless of baseline disease severity, weight, or concomitant PsA.

Keyphrases

patient reported outcomes
prostate cancer
body mass index
weight loss
physical activity
weight gain
radical prostatectomy
body weight
atopic dermatitis
hidradenitis suppurativa